"Liposarcoma, Myxoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A liposarcoma containing myxomatous tissue. (Dorland, 27th ed)
| Descriptor ID |
D018208
|
| MeSH Number(s) |
C04.557.450.550.420.425 C04.557.450.795.465.425
|
| Concept/Terms |
Liposarcoma, Myxoid- Liposarcoma, Myxoid
- Liposarcomas, Myxoid
- Myxoid Liposarcomas
- Myxoid Liposarcoma
|
Below are MeSH descriptors whose meaning is more general than "Liposarcoma, Myxoid".
Below are MeSH descriptors whose meaning is more specific than "Liposarcoma, Myxoid".
This graph shows the total number of publications written about "Liposarcoma, Myxoid" by people in this website by year, and whether "Liposarcoma, Myxoid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Liposarcoma, Myxoid" by people in Profiles.
-
Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients. Radiology. 2021 07; 300(1):E296-E300.
-
A comprehensive review of the current evidence for trabectedin in advanced myxoid liposarcoma. Cancer Treat Rev. 2019 Jan; 72:37-44.
-
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 2017 06; 18(6):812-822.